1. Slattum PW, Peron EP, Hill AM (2014) Alzheimer’s disease. In: DiPiro JT, Talbert RL, Yee GC et al (eds) Pharmacotherapy: a pathophysiologic approach, 9th edn. McGraw-Hill, New York, pp 817–833
2. Steele CD, Steinberg M, Milles G, Jann MW (1999) Recognition and management of early Alzheimer’s disease. JCOM 6:52–67
3. Seltzer B (2007) Donepezil: an update. Expert Opin Pharmacother 8:1011–1023
4. Kuhl DE, Minoshima S, Frey KA, Foster NL, Kilbourn MR, Koeppe RA (2000) Limited donepezil inhibition of acetylcholinesterase measured with positron emission tomography in living Alzheimer cerebral cortex. Ann Neurol 48:391–395
5. Jann MW, Small GW (2009) Cholinesterase inhibitors and similarly acting compounds. Chapter 31.15. In: Sadock BJ, Sadock VA, Ruiz R (eds) Comprehensive textbook of psychiatry, 9th edn. Lippincott, Williams, and Wilkens, Philadelphia, PA, pp. 3089–3099